These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21856700)

  • 21. Bronchodilation subsensitivity to salbutamol after salmeterol.
    Weinberger M
    Lancet; 1995 Oct; 346(8980):968-9. PubMed ID: 7564753
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
    Woolcock A; Lundback B; Ringdal N; Jacques LA
    Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures.
    Verini M; Peroni DG; Piacentini GL; Nicodemo A; Rossi N; Bodini A; Chiarelli F; Boner AL
    Allergy Asthma Proc; 2007; 28(6):691-4. PubMed ID: 18201433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent findings in asthma likely to impact patient care.
    Dykewicz MS; Ledford DK
    Compr Ther; 1998 Apr; 24(4):187-92. PubMed ID: 9598290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    ; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA
    N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK; Bernstein D; Prazma CM; Lincourt WR; Stempel DA
    Allergy Asthma Proc; 2011; 32(2):127-36. PubMed ID: 21189151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current landscape of asthma: a new geometry.
    Wolf BL
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):337-9. PubMed ID: 12392373
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of beclomethasone, salmeterol, and placebo in children with asthma.
    Malozowski S; Stadel BV; Pian LP
    N Engl J Med; 1998 Sep; 339(10):704-5. PubMed ID: 9729145
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-acting bronchodilators in premenstrual exacerbation of asthma.
    Magadle R; Berar-Yanay N; Weiner P
    Respir Med; 2001 Sep; 95(9):740-3. PubMed ID: 11575895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation].
    Wettengel R; Steinkamp G
    Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
    Markham A; Adkins JC
    Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma].
    De Oliveira MA; Jardim JR; Faresin SM; Lucas SR; Nery LE
    Rev Assoc Med Bras (1992); 1998; 44(3):169-75. PubMed ID: 9755543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmeterol xinafoate vs albuterol in asthma: was race a factor?
    Olopade CO
    JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.